Starbucks: Analyst Consensus Estimates

Starbucks (NASDAQ: SBUX) will be reporting their fiscal second quarter financial results today after the close of markets. Analysts have a consensus $115.05 12-month price target on the company, via a total of 34 analysts, with ten analysts having strong buy ratings. Nine analysts meanwhile have buy ratings and 15 have hold ratings. The street high is a $137 price target, and the lowest target sits at $82.

24 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 24 analysts is $6.8 billion; this number has been revised upwards from $6.7 billion at the start of the year. The highest revenue estimate is $7.47 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently 17 analysts who have second-quarter EBITDA estimates. The mean is currently $1.27 billion, with this number having been revised down from $1.35 billion at the start of the year. The street high estimate currently sits at $1.36 billion in EBITDA and the lowest is $1.17 billion.

Analysts estimate that quarterly earnings per share will come in at $0.52, with this number being slightly revised down from $0.59 at the start of the year. Street high currently sits at $0.59 in earnings per share, while the lowest estimate is $0.47 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Related News

Organigram: Raymond James Drops Price To $3.00 Ahead Of Earnings

On Friday, Raymond James reiterated Organigram Holdings (TSX: OGI) (NASDAQ: OGI)‘ market perform rating while...

Monday, November 23, 2020, 03:24:28 PM

Trillion Energy: Research Capital Initiates Coverage With $1.35 Price Target

On September 13, Research Capital Corporation initiated coverage on Trillion Energy (CSE: TCF) with a...

Thursday, September 15, 2022, 12:37:00 PM

Else Nutrition: Canaccord Cuts Price Target After Another Quarter Of Estimate Misses

On November 29th Else Nutrition (TSXV: BABY) announced its third quarter financial results. The company...

Monday, December 6, 2021, 10:20:00 AM

CloudMD: Canaccord Reiterates $3.25 Price Target Following Acquisition

This morning, CloudMD Software & Services (TSXV: DOC) announced that they purchased Rx Infinity, an...

Wednesday, January 27, 2021, 04:01:00 PM

Couche-Tard: BMO Unconcerned With Recent Insider Sales

Last week, Alimentation Couche-Tard Inc. (TSX: ATD.B) insiders filed multiple share sales between both the...

Thursday, October 14, 2021, 04:31:00 PM